Log In
BCIQ
Print this Print this
 

SAR260301

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionPhosphoinositide 3-kinase (PI3K) beta inhibitor
Molecular Target Phosphoinositide 3-kinase (PI3K) beta
Mechanism of ActionPhosphoinositide 3-kinase (PI3K) beta inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard Indication Cancer (unspecified)
Indication DetailsTreat PTEN-deficient tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today